LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Medical Device Concept Reduces Time to Diagnose Infections

By LabMedica International staff writers
Posted on 16 Sep 2015
Image: The droplet-on-thermocouple silhouette real-time polymerase chain reaction device (DOTS qPCR) (Photo courtesy of Dustin Harshman).
Image: The droplet-on-thermocouple silhouette real-time polymerase chain reaction device (DOTS qPCR) (Photo courtesy of Dustin Harshman).
When a patient arrives at a hospital with a serious infection, doctors have precious few minutes to make an accurate diagnosis and prescribe treatment accordingly; however a new diagnostic device may significantly reduce the amount of time necessary to diagnose tissue infections.

Pathogens and infectious diseases in state-of-the-art laboratories are typically detected using a technique called polymerase chain reaction, or PCR and this method involves rapidly heating and cooling DNA molecules from a biological sample in a process called thermal cycling and most PCR tests can take up to an hour or more, and a physician's decision-making window is typically less than ten minutes.

Bioengineers at the University of Arizona (Tucson, AZ, USA) have developed a method called droplet-on-thermocouple silhouette real-time PCR (DOTS qPCR). The technology relies on the measurement of subtle surface tension changes at the interface of a water droplet suspended in an oil medium. The water droplet, which contains the target DNA to be amplified, is moved along a heat gradient in the oil to begin the chain reaction. As more copies of the target DNA are produced, they move towards the oil-water interface, resulting in measurable changes in surface tension. Remarkably, the size of the droplet can be measured using a smartphone camera, providing a method to observe the course of the reaction in real time.

In infective endocarditis diagnosis, DOTS qPCR demonstrates reproducibility, differentiation of antibiotic susceptibility, sub-picogram limit of detection, and thermocycling speeds of up to 28 s/cycle in the presence of tissue contaminants. The DOTS qPCR has sample-to-answer times as short as three and a half minutes. A log-linear relationship with low threshold cycles was presented for real-time quantification by imaging the droplet-on-thermocouple silhouette with a smartphone. DOTS qPCR resolves several limitations of commercially available real-time PCR systems, which rely on fluorescence detection, have substantially higher threshold cycles, and require expensive optical components and extensive sample preparation.

Jeong-Yeol Yoon, PhD, a professor and senior author of the study, said, “With DOTS qPCR we are able to detect amplification and identify the infection after as few as four thermal cycles, while other methods are working with between 18 and 30. The system still works with relatively dirty samples. We can use very minimal processing and still make the detection in a short time. It's easy to use, smartphone-integrated and saves money and labor using expensive equipment. This technology has a lot of commercial potential, and we'd be happy to work with industry to bring it to market.” The study was published on September 4, 2015, in the journal Science Advances.

Related Links:

University of Arizona


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more